en · de · es · pt
cardarine-notes.peptides6823.com › Faq › Identity And Pharmacological Mechanism — Common Mistakes

Identity And Pharmacological Mechanism — Common Mistakes

By Editorial Desk · published 2026-04-09 · last reviewed 2026-04-29 · Faq

A practical reference on Investigational drug: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2026-04-29. Anything still debated is marked as such rather than presented as settled.

Identity and Pharmacological Mechanism

The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.

Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.

Background and Regulatory History

Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.

Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.

GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.

Cardarine at a glance

PropertyValueNotes
Chemical classSynthetic PPARδ agonistNot a steroid or a selective androgen receptor modulator.
Common synonymsCardarine, GW501516, GW-501516, endurobolNames vary by supplier and literature source.
AppearanceWhite to off-white powderConsistent with many small-molecule research chemicals.
SolubilityLow in water; soluble in DMSO and ethanolOften prepared in organic solvent for laboratory work.
Primary targetPPARδ (NR1C2)Nuclear receptor involved in lipid and energy metabolism.

Regulatory Status and Detection Context

A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.

Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.

Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.

Related pages on this site

Background and Regulatory Status

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.

Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.

Reference notes

=== Other injections === There is insufficient evidence on the routine use of injection therapies (autologous blood, platelet-rich plasma, deproteinised haemodialysate, aprotinin, polysulphated glycosaminoglycan, skin derived fibroblasts etc.) for treating Achilles tendinopathy. As of 2014 there was insufficient evidence to support the use of platelet-rich therapies for treating musculoskeletal soft tissue injuries such as ligament, muscle and tendon tears and tendinopathies.

=== Full-thickness tissue engineered oral mucosa === With the advancement of tissue engineering an alternative approach was developed: the full-thickness engineered oral mucosa. Full-thickness engineered oral mucosa is a better simulation of the in vivo situation because they take the anatomical structure of native oral mucosa into account. Problems, such as tissue shortage and donor site morbidity, do not occur when using full-thickness engineered oral mucosa. The main goal when producing full-thickness engineered oral mucosa is to make it resemble normal oral mucosa as much as possible. This is achieved by using a combination of different cell types and scaffolds.

It was also found that 48Ca and 58Fe projectiles had a similar yield for the fusion-fission pathway, suggesting possible future use of 58Fe projectiles in making superheavy elements. It has also been suggested that a neutron-rich flerovium isotope can be formed by quasifission (partial fusion followed by fission) of a massive nucleus. Recently it has been shown that multi-nucleon transfer reactions in collisions of actinide nuclei (such as uranium and curium) might be used to make neutron-rich superheavy nuclei in the island of stability, though production of neutron-rich nobelium or seaborgium is more likely. Theoretical estimates of alpha decay half-lives of flerovium isotopes, support the experimental data. The fission-survived isotope 298Fl, long expected to be doubly magic, is predicted to have alpha decay half-life ~17 days. Making 298Fl directly by a fusion–evaporation pathway is currently impossible: no known combination of target and stable projectile can give 184 neutrons for the compound nucleus, and radioactive projectiles such as 50Ca (half-life 14 s) cannot yet be used in the needed quantity and intensity.

=== Anti-Drug Abuse Act === Spurred by the media craze over the war on drugs the House of Representatives allocated $2 billion in new funding to the federal anti-drug fight in 1986. The House also authorized the use of the military in narcotics control efforts, the death penalty for some drug related crimes, and the admission of illegally obtained evidence in drug trials. In October 1986, Reagan signed the Anti-Drug Abuse Act. It supported much-harsher federal penalties than any other drug legislation in the United States ever passed, with mandatory minimum sentences for the distribution of cocaine and far more severe punishments for the distribution of crack. It outlined a 100-1 discrepancy in prison terms for crack versus powder cocaine. An individual caught with 5 g of crack cocaine would face a five-year sentence. An individual would need to be caught with 500 g of powder cocaine to carry the same sentence. Many scholars have argued that these laws were racist in nature since crack was a drug identified by the media and the public to be associated with black America and powder cocaine with white America. In addition, scholars have pointed out that data from states like New York, where mandatory minimum sentencing had originated a decade earlier, show that mandatory minimums lead to a disproportionate number of arrests of black Americans. The Act was revisited by the administration in 1988 to allow public housing authorities to evict a tenant who allowed drug-related activity to occur on or near public housing premises.

After initiating the blockade, President Trump called on Cuba to "make a deal before it's too late" without specifying any potential terms. On 1 February, Trump said that the U.S. was negotiating with "the highest people in Cuba". However, Drop Site News reported that there were no high-level negotiations occurring between the U.S. and Cuba. On 26 February, the Miami Herald reported that the U.S. had been speaking to former First Secretary Raúl Castro's grandson, Raúl Guillermo Rodríguez Castro, who is not a senior leader of the Cuban Communist Party. The next day, Trump again claimed to be negotiating with the Cuban government saying that the U.S. could "have a friendly takeover of Cuba". In a March address on Cuban television, First Secretary Díaz-Canel confirmed that negotiations with the U.S. were taking place. In March 2026, the Cuban government announced that it would release 51 political prisoners in the coming days. The move was described as being taken "in a spirit of goodwill" and followed diplomatic engagement with the Holy See, which has been involved in dialogue with Cuban authorities. The government stated that the prisoners had served a significant portion of their sentences and demonstrated good conduct.

Sources: en.wikipedia.org

Notes from published material

== Absorption, metabolism, and excretion == Tocotrienols and tocopherols, the latter including the stereoisomers of synthetic alpha-tocopherol, are absorbed from the intestinal lumen, incorporated into chylomicrons, and secreted into the portal vein, leading to the liver. Absorption efficiency is estimated at 51% to 86%, and that applies to all of the vitamin E family – there is no discrimination among the vitamin E vitamers during absorption. Bile is necessary for chylomicron formation, so disease conditions such as cystic fibrosis result in biliary insufficiency and vitamin E malabsorption. When consumed as an alpha-tocopheryl acetate dietary supplement, absorption is promoted when consumed with a fat-containing meal. Unabsorbed vitamin E is excreted via feces. Additionally, vitamin E is excreted by the liver via bile into the intestinal lumen, where it will either be reabsorbed or excreted via feces, and all of the vitamin E vitamers are metabolized and then excreted via urine. Upon reaching the liver, RRR-alpha-tocopherol is preferentially taken up by alpha-tocopherol transfer protein (α-TTP). All other forms are degraded to 2'-carboxethyl-6-hydroxychromane (CEHC), a process that involves truncating the phytic tail of the molecule, then either sulfated or glucuronidated. This renders the molecules water-soluble and leads to excretion via urine. Alpha-tocopherol is also degraded by the same process, to 2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychromane (α-CEHC), but more slowly because it is partially protected by α-TTP.

Ann Lawthom, lately Headteacher, Rhondda Special School, Trealaw, Rhondda. For services to Education. Hilda Blanche Le Cras. For services to Horse Driving for the Disabled and to the Royal British Legion on Guernsey. Elizabeth May Leake. For charitable services in Clenchwarton, Norfolk. William Gordon John Leckie, Managing Director, Cneff Hydro Hotel, Perthshire. For services to the Hotel Industry and to Tourism. Bryan Neville Lee. For services to the Samaritans and to the community in Doncaster. Winifred Elizabeth Lees. For political and public service. Jacqueline Margaret Leete. For services to the community in Headley, Hampshire. Donald Clement Lefever. For services to the Butler Trust. Shiu-Wing Leung, Executive Officer, Ministry of Defence. Joan Lewin. For services to the Historical Association. Ann Lewis, Teacher in Charge, Widden Family Centre, Gloucester. For services to Pre-School Education. Peter Reginald Lewis, Sub-Officer (Retained), North Wales Fire Service. For services to the Fire Service. Maurice George Lihou. For services to Young Handicapped People on Guernsey. Sandra Elizabeth Linnett, lately Sales and Computer Clerk, Kopex International Ltd. For services to Industry. Rose Helena Lloyd. For services to St. David's Church, Hundleton. Adrian Neville Barrett Loach, Assistant Group Scout Leader, Bristol. For services to Scouting. Rebecca McCausland Lockhead. For public service Jean Elizabeth Lockwood. For services to the community in Amersham, Buckinghamshire. The Reverend Roy Frederick Lodge, Chaplain, Her Majesty's Prison Brockhill.

=== Development === Scandal was renewed for a fifth season on May 7, 2015, by ABC. The series will continue to air at Thursdays in the timeslot 9:00 p.m. E.T. like the previous season, as it was moved to the timeslot to make room for ShondaLand Production Company's new TV series, How to Get Away with Murder. Production began on May 21, 2015, when Rhimes announced on Twitter that the writers were in full swing mapping the fifth season. The remaining fall schedule for ABC was announced on November 16, 2015, where it was announced that Scandal would air nine episodes in the fall with the fall finale to air on November 19, 2015, just like the rest of ABC's primetime lineup "TGIT" Grey's Anatomy and How To Get Away with Murder, which was the same last year. The remaining 12 episodes will air after the winter break, beginning on February 11, 2016, as a result of ABC airing the television miniseries Madoff over two nights on February 3–4, 2016 in the same time-slot as Scandal and Grey's Anatomy. The show was renewed by ABC for a sixth season on March 3, 2016.

The carboniferous rocks of the Yorkshire coalfield further east have produced a rolling landscape with hills, escarpments and broad valleys in the outer fringes of the Pennines. In this landscape there is widespread evidence of both current and former industrial activity. There are numerous derelict or converted mine buildings and recently landscaped former spoil heaps. The scenery is a mixture of built up areas, industrial land with some dereliction, and farmed open country. Ribbon developments along transport routes including canal, road and rail are prominent features of the area although some remnants of the pre industrial landscape and semi-natural vegetation still survive. However, many areas are affected by urban fringe pressures creating fragmented and downgraded landscapes and ever present are urban influences from major cities, smaller industrial towns and former mining villages. In the Magnesian Limestone belt to the east of the Leeds and Wakefield areas is an elevated ridge with smoothly rolling scenery, dissected by dry valleys. Here, there is a large number of country houses and estates with parkland, estate woodlands, plantations and game coverts. The rivers Aire and Calder drain the area, flowing from west to east.

== Places == Greece (ISO 3166/NATO:GR) Grand Rapids, Michigan, United States Grand Rapids, Minnesota, United States Giurgiu County, Romania Grisons, a Swiss canton (ISO:CH-GR) Groningen (province), Netherlands (ISO:NL-GR) Province of Grosseto, Tuscany, Italy Garden Reach, Kolkata, West Bengal, India

Sources: en.wikipedia.org

Background from the literature

=== Co-evolution of rRNA and proteins === The structure of the 40S subunit revealed that the eukaryote-specific proteins (rpS7, rpS10, rpS12 and RACK1), as well as numerous eukaryote-specific extensions of proteins, are located on the solvent-exposed side of the small subunit. Here, they participate in the stabilization of rRNA expansion segments. Moreover, the beak of the 40S subunit is remodeled, as rRNA has been replaced by proteins rpS10 and rpS12. As observed for the 40S subunit, all eukaryote-specific proteins of the 60S subunit (RPL6, RPL22, RPL27, RPL28, RPL29 and RPL36) and many extensions are located at the solvent-exposed side, forming an intricate network of interactions with eukaryotic-specific RNA expansion segments. RPL6, RPL27 and RPL29 mediate contacts between the ES sets ES7–ES39, ES31–ES20–ES26 and ES9–ES12, respectively and RPL28 stabilized expansion segment ES7A.

Animals that characterize the Appalachian forests include five species of tree squirrels. The most commonly seen is the low to moderate elevation eastern gray squirrel (Sciurus carolinensis). Occupying similar habitat is the slightly larger fox squirrel (Sciurus niger) and the much smaller southern flying squirrel (Glaucomys volans). More characteristic of cooler northern and high elevation habitat is the red squirrel (Tamiasciurus hudsonicus), whereas the Appalachian northern flying squirrel (Glaucomys sabrinus fuscus), which closely resembles the southern flying squirrel, is confined to northern hardwood and spruce–fir forests. As familiar as squirrels are the eastern cottontail rabbit (Silvilagus floridanus) and the white-tailed deer (Odocoileus virginianus). The latter in particular has greatly increased in abundance as a result of the extirpation of the eastern wolf (Canis lupus lycaon) and the North American cougar. This has led to the overgrazing and browsing of many plants of the Appalachian forests, as well as destruction of agricultural crops. Other deer include the moose (Alces alces ), found only in the north, and the elk (Cervus canadensis), which, although once extirpated, is now making a comeback, through transplantation, in the southern and central Appalachians. In Quebec, the Chic-Chocs host the only population of reindeer (Rangifer tarandus) south of the St. Lawrence River. An additional species that is common in the north but extends its range southward at high elevations to Virginia and West Virginia is the varying or snowshoe hare (Lepus americanus).

Potatoes naturally produce solanine and chaconine, a related glycoalkaloid, as a defense mechanism against insects, disease, and herbivores. Potato leaves, stems, and shoots are naturally high in glycoalkaloids. When potato tubers are exposed to light, they turn green and increase glycoalkaloid production. This is a natural defense to help prevent the uncovered tuber from being eaten. The green colour is from chlorophyll, and is itself harmless. However, it is an indication that increased level of solanine and chaconine may be present. In potato tubers, 30–80% of the solanine develops in and close to the skin, and some potato varieties have high levels of solanine. Some potato diseases, such as late blight, can dramatically increase the levels of glycoalkaloids present in potatoes. Tubers damaged in harvesting and/or transport also produce increased levels of glycoalkaloids; this is believed to be a natural reaction of the plant in response to disease and damage. Also, the tuber glycoalkaloids (such as solanine) can be affected by some chemical fertilization. For example, different studies have reported that glycoalkaloids content increases by increasing the concentration of nitrogen fertilizer. Green colouring under the skin strongly suggests solanine build-up in potatoes, although each process can occur without the other. A bitter taste in a potato is another – potentially more reliable – indicator of toxicity. Because of the bitter taste and appearance of such potatoes, solanine poisoning is rare outside conditions of food shortage.

=== Glucose detection === Paper-based microfluidic devices have been designed to monitor a wide variety of medical ailments. Glucose plays an important role in diabetes and cancer, and it can be detected through a catalytic cycle involving glucose oxidase, hydrogen peroxide, and horseradish peroxidase that initiates a reaction between glucose and a color indicator, frequently potassium iodide, on a paper-based microfluidic device. This is an example of colorimetric detection. The first paper-based microfluidic device, developed by George Whitesides' group at Harvard, was able to simultaneously detect protein as well as glucose via color-change reactions (potassium iodide reaction for glucose and tetrabromophenol blue reaction for the protein BSA). The bottom of the paper device is inserted into a sample solution prepared in-lab, and the amount of color change is observed. More recently, a paper-based microfluidic device using colorimetric detection was developed to quantify glucose in blood plasma. Blood plasma is separated from whole blood samples on a wax-printed device, where red blood cells are agglutinated by antibodies and the blood plasma is able to flow to a second compartment for the color-change reaction. Electrochemical detection has also been used in these devices. It provides greater sensitivity in quantification, whereas colorimetric detection is primarily used for qualitative assessments. Screen-printed electrodes and electrodes directly printed on filter paper have been used.

Sources: en.wikipedia.org

Frequently asked questions

What is cardarine?

Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.

How does cardarine interact with the body?

It binds to and activates PPARδ, a nuclear receptor that regulates genes related to fatty acid oxidation and energy use. This activation alters transcription in tissues such as skeletal muscle and liver. The full range of downstream effects in humans is not fully established.

Is cardarine found naturally?

No, cardarine is not known to occur naturally in plants, animals, or humans. It is a synthetic molecule produced for laboratory research. Products labeled as cardarine should therefore be treated as manufactured chemicals with variable purity.

Is cardarine a selective androgen receptor modulator?

No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.

Network